Camber Pharmaceuticals adds 100 count to Generic Neurontin®

Piscataway, NJ, June 6, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Gabapentin 100 count to its product line.
Last October, Camber launched Gabapentin Capsules 100, 300 and 400 mg in 500 count bottles.
Gabapentin Capsules, USP are available in a 100, 300 and 400 mg in 100 and 500 count bottles.
To learn more about Gabapentin Capsules, USP, please visit https://www.camberpharma.com/gabapentincapsules
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection